These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 7889006

  • 1. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M, Yabe H, Hattori K, Hinohara T, Morimoto T, Kato S, Kusunoki A.
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [Abstract] [Full Text] [Related]

  • 2. Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors.
    Cela ME, Holladay MS, Rooney CM, Richardson S, Alexander B, Krance RA, Brenner MK, Heslop HE.
    Bone Marrow Transplant; 1996 Feb; 17(2):243-7. PubMed ID: 8640174
    [Abstract] [Full Text] [Related]

  • 3. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Feb; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX, Jun CY, Yu ZX.
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [Abstract] [Full Text] [Related]

  • 6. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation.
    Sugita K, Soiffer RJ, Murray C, Schlossman SF, Ritz J, Morimoto C.
    Transplantation; 1994 May 27; 57(10):1465-73. PubMed ID: 7910987
    [Abstract] [Full Text] [Related]

  • 7. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H, Nakamura H, Tominaga N, Teshima H, Hiraoka A, Shibata H, Masaoka T.
    Bone Marrow Transplant; 1994 Feb 27; 13(2):181-5. PubMed ID: 7515741
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation.
    Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor CA.
    Bone Marrow Transplant; 1997 Jun 27; 19(11):1069-77. PubMed ID: 9193748
    [Abstract] [Full Text] [Related]

  • 10. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS, Riley R, Hamilton BL, Paupe J, Perez D, Levy RB.
    Bone Marrow Transplant; 1994 Nov 27; 14(5):725-35. PubMed ID: 7889005
    [Abstract] [Full Text] [Related]

  • 11. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D, García-López J, Sureda A, Canals C, Ferra C, Cancelas JA, Berlanga JJ, Brunet S, Boqué C, Picón M, Torrico C, Amill B, Martino R, Martínez C, Martín-Henao G, Domingo-Albós A, Grañena A.
    Bone Marrow Transplant; 1997 Dec 27; 20(11):945-52. PubMed ID: 9422473
    [Abstract] [Full Text] [Related]

  • 12. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec 27; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 13. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD, Becker EE, LaBelle JL, Truitt RL.
    J Immunol; 1999 Dec 15; 163(12):6479-87. PubMed ID: 10586039
    [Abstract] [Full Text] [Related]

  • 14. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.
    Haematologica; 2008 Mar 15; 93(3):423-30. PubMed ID: 18287134
    [Abstract] [Full Text] [Related]

  • 15. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C, Schirutschke H, Ehninger G, Bornhäuser M, Platzbecker U.
    Clin Cancer Res; 2007 May 15; 13(10):2916-22. PubMed ID: 17504991
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A, Salooja N, Russell-Jones R.
    J Eur Acad Dermatol Venereol; 2004 May 15; 18(3):279-84. PubMed ID: 15096136
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population.
    Abraham VS, Sachs DH, Sykes M.
    J Immunol; 1992 Jun 15; 148(12):3746-52. PubMed ID: 1534824
    [Abstract] [Full Text] [Related]

  • 19. Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation.
    Charmot D, Ragueneau M, Olive D, Maraninchi D, Mawas C.
    Bone Marrow Transplant; 1987 Aug 15; 2(2):183-94. PubMed ID: 2901879
    [Abstract] [Full Text] [Related]

  • 20. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S, Chen H, Wang H, Ma J, Pan S, Xue M, Zhu L, Liu J, Xiao M, Zhou L.
    Chin Med J (Engl); 2001 Feb 15; 114(2):191-5. PubMed ID: 11780205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.